Literature DB >> 23572493

Prolonged mean VO2 response time in systolic heart failure: an indicator of impaired right ventricular-pulmonary vascular function.

Neal A Chatterjee1, Ryan M Murphy, Rajeev Malhotra, Bishnu P Dhakal, Aaron L Baggish, Paul P Pappagianopoulos, Stacyann S Hough, Marc J Semigran, Gregory D Lewis.   

Abstract

BACKGROUND: In patients with left ventricular systolic dysfunction (LVSD), the rate at which oxygen uptake (VO2) increases on initiation of exercise is inadequate to match metabolic demands. To gain mechanistic insights into delayed VO2 kinetics in LVSD, we simultaneously assessed hemodynamic measurements, ventilatory parameters, and peripheral oxygen usage during exercise. METHODS AND
RESULTS: Forty-two patients with symptomatic LVSD (age, 59±2 years [mean±SEM]; LV ejection fraction, 30±1%) and 17 controls (LV ejection fraction, 68±1%) underwent maximum upright cycle ergometry cardiopulmonary exercise testing. Hemodynamic monitoring and first-pass radionuclide ventriculography were performed at rest and during exercise. VO2 kinetics were quantified by mean response time (MRT), which was significantly longer in patients with LVSD compared with controls (64±3 versus 45±5 s; P=0.004). In LVSD patients, MRT was associated with higher biventricular filling pressures and reduced cardiac output during early exercise. LVSD patients with MRT ≥60 s, compared with LVSD subjects with MRT <60 s, demonstrated greater impairment in right ventricular-pulmonary vascular function during exercise as evidenced by lower right ventricular ejection fraction (35±2 versus 45±2%; P=0.03), steeper increment in transpulmonary gradient relative to cardiac output (3.7 versus 2.2 mm Hg/L; P<0.001), and increased ventilatory dead-space fraction (17±1 versus 12±2%; P=0.03). In contrast, MRT was not associated with LV ejection fraction (rest, exercise), PaO2, hemoglobin, or resting pulmonary function test results.
CONCLUSIONS: Delayed oxygen uptake on initiation of exercise (ie, MRT ≥60 s) in LVSD is closely related to impaired right ventricular-pulmonary vascular function and may represent an important surrogate for inability to augment RV performance during physical activity in patients with heart failure.

Entities:  

Keywords:  exercise physiology; exercise testing; heart failure

Mesh:

Year:  2013        PMID: 23572493      PMCID: PMC5935663          DOI: 10.1161/CIRCHEARTFAILURE.112.000157

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  47 in total

1.  Delayed VO2 kinetics during ramp exercise: a criterion for cardiopulmonary exercise capacity in chronic heart failure.

Authors:  K Meyer; M Schwaibold; R Hajric; S Westbrook; D Ebfeld; D Leyk; H Roskamm
Journal:  Med Sci Sports Exerc       Date:  1998-05       Impact factor: 5.411

2.  A four-minute submaximal constant work rate exercise test to assess cardiovascular functional class in chronic heart failure.

Authors:  R Belardinelli; Y Y Zhang; K Wasserman; A Purcaro; P G Agostoni
Journal:  Am J Cardiol       Date:  1998-05-15       Impact factor: 2.778

3.  Contribution of PO2, P50, and Hb to changes in arteriovenous O2 content during exercise in heart failure.

Authors:  G B Perego; G C Marenzi; M Guazzi; P Sganzerla; E Assanelli; P Palermo; B Conconi; G Lauri; P G Agostoni
Journal:  J Appl Physiol (1985)       Date:  1996-02

4.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.

Authors:  K D Aaronson; J S Schwartz; T M Chen; K L Wong; J E Goin; D M Mancini
Journal:  Circulation       Date:  1997-06-17       Impact factor: 29.690

5.  Blood flow dynamics in heart failure.

Authors:  J K Shoemaker; H L Naylor; C S Hogeman; L I Sinoway
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

6.  Non-invasive measurement of stroke volume during exercise in heart failure patients.

Authors:  P G Agostoni; K Wasserman; G B Perego; M Guazzi; G Cattadori; P Palermo; G Lauri; G Marenzi
Journal:  Clin Sci (Lond)       Date:  2000-05       Impact factor: 6.124

7.  Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management.

Authors:  D L Moraes; W S Colucci; M M Givertz
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

8.  31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure.

Authors:  B M Massie; M Conway; R Yonge; S Frostick; P Sleight; J Ledingham; G Radda; B Rajagopalan
Journal:  Am J Cardiol       Date:  1987-08-01       Impact factor: 2.778

9.  Long-term reproducibility of respiratory gas exchange measurements during exercise in patients with stable cardiac failure.

Authors:  J S Janicki; S Gupta; S T Ferris; P A McElroy
Journal:  Chest       Date:  1990-01       Impact factor: 9.410

Review 10.  Characterization of VO2 kinetics during heavy exercise.

Authors:  T J Barstow
Journal:  Med Sci Sports Exerc       Date:  1994-11       Impact factor: 5.411

View more
  10 in total

1.  Physical activity and fitness in the community: the Framingham Heart Study.

Authors:  Matthew Nayor; Ariel Chernofsky; Nicole L Spartano; Melissa Tanguay; Jasmine B Blodgett; Venkatesh L Murthy; Rajeev Malhotra; Nicholas E Houstis; Raghava S Velagaleti; Joanne M Murabito; Martin G Larson; Ramachandran S Vasan; Ravi V Shah; Gregory D Lewis
Journal:  Eur Heart J       Date:  2021-11-21       Impact factor: 35.855

Review 2.  Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity.

Authors:  Jenna L Taylor; Amanda R Bonikowske; Thomas P Olson
Journal:  Front Cardiovasc Med       Date:  2021-09-03

3.  Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure.

Authors:  Gregory D Lewis; Marc J Semigran; Michael M Givertz; Rajeev Malhotra; Kevin J Anstrom; Adrian F Hernandez; Monica R Shah; Eugene Braunwald
Journal:  Circ Heart Fail       Date:  2016-05       Impact factor: 8.790

4.  The value of cardiopulmonary exercise testing in the diagnosis of pulmonary hypertension.

Authors:  Qin Luo; Xue Yu; Zhihui Zhao; Qing Zhao; Xiuping Ma; Qi Jin; Lu Yan; Yi Zhang; Zhihong Liu
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

5.  Comparison of V̇O2-Kinetic Parameters for the Management of Heart Failure.

Authors:  Jonathan Wagner; Max Niemeyer; Denis Infanger; Otmar Pfister; Jonathan Myers; Arno Schmidt-Trucksäss; Raphael Knaier
Journal:  Front Physiol       Date:  2021-11-25       Impact factor: 4.566

6.  Functional improvement following direct interventional leaflet repair of severe tricuspid regurgitation.

Authors:  Martin J Volz; Isabel Hoerbrand; Mathias H Konstandin; Derliz Mereles; Celine Weiss; Gregor Warnecke; Norbert Frey; Matthias Aurich; Philip W Raake
Journal:  ESC Heart Fail       Date:  2022-02-08

7.  Oxygen uptake kinetics and chronotropic responses to exercise are impaired in survivors of severe COVID-19.

Authors:  Igor Longobardi; Danilo Marcelo Leite do Prado; Karla Fabiana Goessler; Matheus Molina Meletti; Gersiel Nascimento de Oliveira Júnior; Danieli Castro Oliveira de Andrade; Bruno Gualano; Hamilton Roschel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-19       Impact factor: 5.125

8.  Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology.

Authors:  Marco Guazzi; Matthias Wilhelm; Martin Halle; Emeline Van Craenenbroeck; Hareld Kemps; Rudolph A de Boer; Andrew J S Coats; Lars Lund; Donna Mancini; Barry Borlaug; Gerasimos Filippatos; Burkert Pieske
Journal:  Eur J Heart Fail       Date:  2022-07-31       Impact factor: 17.349

9.  Prolonged mean response time in older adults with cardiovascular risk compared to healthy older adults.

Authors:  Kazuyuki Kominami; Masatoshi Akino
Journal:  BMC Sports Sci Med Rehabil       Date:  2022-09-23

10.  Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial.

Authors:  Gregory D Lewis; Rajeev Malhotra; Adrian F Hernandez; Steven E McNulty; Andrew Smith; G Michael Felker; W H Wilson Tang; Shane J LaRue; Margaret M Redfield; Marc J Semigran; Michael M Givertz; Peter Van Buren; David Whellan; Kevin J Anstrom; Monica R Shah; Patrice Desvigne-Nickens; Javed Butler; Eugene Braunwald
Journal:  JAMA       Date:  2017-05-16       Impact factor: 56.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.